Cognosante is the famous Corporate Investor, which was founded in 1987. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the Mclean.
The top activity for fund was in 2018. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Protenus. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most successful fund investment fields, there are Software, Analytics.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Cognosante, startups are often financed by LionBird, TEDCO, TCP Venture Capital. The meaningful sponsors for the fund in investment in the same round are LionBird, Arthur Ventures, TEDCO. In the next rounds fund is usually obtained by LionBird, Kaiser Permanente Ventures, F-Prime Capital.
|Actium Funds||Salt Lake City, United States, Utah|
|Anonymous Trust||California, San Francisco, United States|
|aws Mittelstandsfonds||Austria, Vienna|
|Belgian Investment Company for Developing Countries||Belgium, Brussels, Brussels Hoofdstedelijk Gewest|
|Chengbo Investment||China, Tianjin, Tianjin|
|Coral Reef IO||England, London, United Kingdom|
|CTNext||Connecticut, Rocky Hill, United States|
|Gelmart International||New York, New York, United States|
|Kaihuo Shangwu||China, Hunan, Longhui|
|Koudai Jianzhi||China, Guangdong, Guangzhou|
|Oakview Group||California, Los Angeles, United States|
|River SaaS Capital||Ohio, United States, Westlake|
|Riverhead Capital||India, Maharashtra, Mumbai|
|Sycamore Ventures||New Jersey, Princeton, United States|
|Taiko Pharmaceutical||Japan, Osaka, Osaka Prefecture|
|Vertex Asia Fund||Central, Central Region, Singapore|
|Xuebao No.1||Beijing, China, Haidian|
|Zhongyi Venture Capital||-|
|$11M||22 Jan 2018||Baltimore, Maryland, United States|
|$4M||26 Jan 2016||Baltimore, Maryland, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.